DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.7% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $376.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/16/2026ACC: 0001310204-26-000020
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$376.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$125.40
Trade value
$376.20K
% of position
1.7%
6/15/2026
174.65K→171.65K
Total
Net shares
−3K
Net value
-$376.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | S · Sale | −3K | $125.40 | $376.20K | 1.7% | 174.65K | 171.65K |
| Total | −3K | -$376.20K | ||||||
Derivative Transactions0
No derivative transactions reported